A new sensitive method for determination of intracellular 1-β-D-arabinofuranosylcytosine 5′-triphosphate content in human materials in vivo

Cancer Research

Volumn 56, Issue 8, 1996, Pages 1800-1804

  Yamauchi, Takahiro ^a   Ueda, Takanori ^a   Nakamura, Toru ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; CYTARABINE DERIVATIVE; CYTARABINE TRIPHOSPHATE; DRUG METABOLITE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BLAST CELL; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ALKALINE PHOSPHATASE; ARABINOFURANOSYLCYTOSINE TRIPHOSPHATE; BLAST CRISIS; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; CYTARABINE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; MYELODYSPLASTIC SYNDROMES; RADIOIMMUNOASSAY; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0029923110     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ellison, R. R., Holland, J. F. Weil, M., Jacquillat, C., Botron, M., Bernard, J., Sawitsky, A., Rosner, F , Gussoff, B., Silver, R T , Karonas, A , Cuttner, J., Spurr, C. L., Hayes, D. M., Blom, J., Leone, L A , Hanrani, F . Kyle, R., Hutchinson, J L , Forcier, R J., and Moon, J. H. Arabinocytosine' a useful agent in the treatment of acute leukemia in adults Blood, 32: 507-523, 1968
2. Nakamura, T. Review on internal medicine (1988) Recent progress in treatment of haematological malignancies. I Drugs, 1) anticancer agents Jpn. J Med., 78: 753-758. 1989.
3. Baccarani, M., Zaccaria, A., Bandini, G , Cavazzini, G., Fanin, R., and Tura, S. Low dose arabinosyl cytosine for treatment of myelodjsplastic syndromes and subacute myeloid leukemia. Leuk. Res., 7: 539-545, 1983.
4. Momparler, R. Effects of cytosine arabinoside 5′-triphosphate on mammalian DNA polymerase Biochem Biophys Res Commun., 34, 465-471, 1969.
5. Rustum, Y. M , and Preisler, H D. Correlation between leukemic cell retention of 1-β-D-arabinofuranosylcytosine 5′-tnphosphate and response to therapy Cancer Res., 39, 42-49, 1979.
6. Shimada, N., Ueda, T., Yokoshima, T., Oh-ishi, J., and Oh-oka, T A sensitive and specific radioimmunoassay for 1-β-D-arabino-furanosylcytosine Cancer Lett., 24: 173-178, 1984.
7. 4-behenoyl-1-β-D-arabmofuranosy!cytosine in patients with acute leukemia. Cancer Res , 43: 3412-3416, 1983
8. Ueda, T., Kamiya, K., Urasaki, Y., Wataya, S , Kawai, Y , Tsutani, H , Sugiyama, M., and Nakamura, T. Clinical pharmacology of 1-β-D-arabinofuranosylcytosine-5′-stearylphosphate, an orally administered long-acting derivative of low-dose 1-β-D-arabinofuranosylcytosme Cancer Res., 54: 109-113, 1994.
9. Fallon, H. J , Frei, E , III, Davidson, J. D., Trier, J S., and Burk, D. Leukocyte preparations from human blood, evaluation of their morphologic and metabolic state. J. Lab. Clin. Med , 59: 779-791, 1962.
10. Khym, J. K. An analytical system for rapid separation of tissue nucleotides at low pressures on conventional anion exchangers Clin Chem . 21: 1245-1252, 1975
11. Kawasaki, H., Kuwabara, H., Hori, H , Higashiyama, M., Ohkubo, T., and Sakurat, M. Intracellular dCTP/ara-CTP ratio and the cytotoxic effects of ara-C. Cancer Invest, 9: 409-413, 1991.
12. 2-isopentenyl) adenosine, a component of the transfer nbonucleic acid of yeast and of mammalian tissue, methods of isolation, and characterization Biochemistry, 6 1837-1848, 1967.
13. Garret, C., and Santi, D V A rapid and sensitive high pressure liquid chromatography assay for deoxynucleoside triphosphates in cell extracts. Anal. Biochem., 99: 268-273, 1979.
14. Plunkett, W., Hug, V., Keating, M. J , and Chubb, S. Quantuation of 1-β-D-arabinofuranosylcytosine 5′-triphosphate in leukemic cells from bone marrow and peripheral blood of patients receiving 1-β-D-arabinofuranosylcytosine therapy. Cancer Res , 40: 588-591, 1980.
15. Pallavicini, M. G., and Mazrimas, J. A. High-performance liquid chromatographic analysis of cytosine arabinoside and metabolites in biological samples. J. Chromatogr., 183: 449-458, 1980.
16. Chiba, P., Szekeres, T., and Jager, W. Determination of pyrimidine deoxynucleoside triphosphates in leukemia cell extracts containing 1-beta-D-arabinofuranosylcytosine triphosphate. Eur. J. Clin. Chem. Clin. Biochem 29: 385-389, 1991.
17. Rustum, Y. M., Riva, C., and Preisler, H. D. Pharmacokinetic parameters of 1-β-D-arabinofuranosylcytosine (ara-C) and their relationship to intracellular metabolism of ara-C, toxieity, and response of patients with acute nonlymphocytic leukemia treated with conventional and high-dose ara-C Semin. Oncol, 14: 143-148, 1987.
18. Riva-Laveille, C., Ressayre, C., Barra, Y., Carcassonne, Y., and Iliadis, A. Calculation of individual dosage regimen of cytosine arabinoside (ara-C) based on metabolite levels in leukemic cells. Ther. Drug Monit., 16: 375-379, 1994.
19. Kufe, D., Spriggs, D., Egan, E. M., and Munroe, D. Relationships among ara-CTP pools, formation of (ara-C)DNA, and cytotoxicity of human leukemic cells. Blood, 64, 54-58, 1984.
20. Chou, T. C., Arlin, Z , Clarkson, B. D., and Philips, F. S. Metabolism of 1-β-D-arabinofuaranosylcytosine in human leukemic cells. Cancer Res., 37: 3561-3570, 1977.
21. Spriggs, D. R Robbins, G., Ohno, Y., and Kufe, D. W. Detection of 1-β-D-arabinofuranosylcytosine incorporation into DNA in vivo. Cancer Res., 47: 6532-6536, 1987.